Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael J. Quist
Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
PAK4 Inhibition Improves PD-1 Blockade Immunotherapy
Nature Cancer
Related publications
Frequent MED12 Mutations in Phyllodes Tumours of the Breast
British Journal of Cancer
Cancer Research
Oncology
Mapping Actionable Pathways and Mutations in Brain Tumours Using Targeted RNA Next Generation Sequencing
Acta neuropathologica communications
Forensic Medicine
Molecular Neuroscience
Pathology
Neurology
Cellular
Massively Parallel Sequencing of Phyllodes Tumours of the Breast Reveals Actionable Mutations, andTERTpromoter Hotspot Mutations andTERTgene Amplification as Likely Drivers of Progression
Journal of Pathology
Forensic Medicine
Pathology
Targeted Next-Generation Sequencing Identifies Actionable Targets in Estrogen Receptor Positive and Estrogen Receptor Negative Endometriod Endometrial Cancer
Frontiers in Pharmacology
Pharmacology
Pd34-04 Actionable Targets in Patients With Cisplatin-Resistant Advanced Germ Cell Tumors
Journal of Urology
Urology
Actionable Mutations in Canine Hemangiosarcoma
PLoS ONE
Multidisciplinary
Novel Mutations in Actionable Breast Cancer Genes by Targeted Sequencing in an Ethnically Homogenous Cohort
BMC Medical Genetics
Genetics
Next Generation Sequencing in Synovial Sarcoma Reveals Novel Gene Mutations
Oncotarget
Oncology
Macrophages Associated With Tumors as Potential Targets and Therapeutic Intermediates
Nanomedicine
Development
Materials Science
Nanoscience
Medicine
Bioengineering
Nanotechnology
Biomedical Engineering
